Fairchem Organics Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/vvg7cvjguat8gmb7muxeova3.pdf

Key Takeaways


Revenue Breakdown: What Drove the Decline


Dimer Acid: The Margin Squeeze Mechanics

Jhaveri: "Historically, what we have been doing is we have been pricing our Dimer Acid at marginally lower price than what is the landed cost of Chinese Dimer Acid plus the non-cenvatable custom duty. So, if that works out to say X rupees, our price would be X minus INR 2 or something like that."

Margin Outlook: The Path Back to Double Digits

Jhaveri: "All those things will have to fall in place simultaneously... easing of some raw material prices, U.S. export revival of both Dimer Acid and Isostearic Acid and this our animal feed thing, which we are planning. All these things should fall in line. And that would surely then be our EBITDA margin would be in double digits, 100%."

New Products: Animal Feed and the Pipeline


U.S. Market: Tariff Dependency and Structural Opportunity

Jhaveri: "It is unfortunate. It is more torturous for us than for you. We understand that it is torturous for all the investors, but you will also appreciate that it will be double the thing for us because we remain committed on that and we need to deliver on this. So, the onus is more on us as of now."

Competitive and Market Structure

Jhaveri: "These manufacturers, these refineries also know that the soya acid oil, if there is more than one buyer, they can always keep the prices at an artificially elevated level compared to what was prevailing in earlier years or earlier quarters."

Guidance & Commitments

CommitmentSpecificsTimeline
Animal feed trial (domestic)First commercial production trialMarch 2026 or at most April–June 2026 quarter
Animal feed trial (exports)Trial runs for export-grade productDecember 2025 or January 2026
Animal feed commercial productionCommercial production begins, gradual ramp-upApril–June 2026 quarter
Margin recoveryImprovement in EBITDA marginHoping for January–March 2026 quarter; if not, "certainly by April 2026"
Double-digit EBITDA marginReturn to double digitsWhen raw material eases, U.S. exports revive, and animal feed materializes simultaneously
U.S. export revivalDimer Acid exports resumeWhen India closes a tariff deal with U.S. at 10–15%
Isostearic Acid export ramp-upSteady phased growth in non-U.S. exportsOnce European regulatory registrations are completed

Key Metrics

MetricQ2 FY26
Revenue from operations₹112 cr, declined 20% YoY
EBITDA₹4 cr, declined 52% YoY
EBITDA margin3.77%
Net profit after tax~₹80 lakh, PAT margin 0.72%
H1 FY26 revenue from operations₹243 cr, declined ~20% YoY
H1 FY26 EBITDA₹9 cr, declined ~69% YoY
H1 FY26 EBITDA margin3.87%
H1 FY26 net profit after tax₹2 cr, declined ~89% YoY
Domestic sales share91.22% of total revenue
Export share8.78% of total revenue
Volume processed11,492 metric tons
Volume sold10,062 metric tons
Linoleic Acid revenue share33%, down from 40% in Q1 FY26
Dimer Acid revenue share33%, up from 27% in Q1 FY26
Chinese Dimer Acid price declineMore than 25% over the last 24 months
Dimer Acid market share~65% retained in India
Basic custom duty on imported Dimer Acid7.5%